Abstract
The aim of this review is the coverage of recent literature (2007-2009) on bioactive compounds containing benzoxadiazole, benzothiadiazole and benzotriazole nucleus, as central core as well as substituent in the context of SAR studies. Reviews sections are organized on the basis of heterocycle contained in drug structure and subdivided for represented main activities (Antitumorals, antiviral, antibacterial, antifungal agents, analgesics, etc.).
Keywords: Heterocycles, benzoxadiazole, benzofuroxan, benzothiadiazole, benzotriazole, biologically active compounds, Antitumorals, GSTs, NBDHEX, MRP1, Cisplatin, Electrospray ionization mass spectrometry, fluorescence analysis, TRAF6 ligase assay, Mycobacterium tuberculosis, GOLD, FLEXX, whole-cell assay, Mycobacterium smegmatis, P. aeruginosa, S. aureus, Helicobacter pylori, Trypanosoma cruzi, ESR spectroscopy, Tulahuen 2, CL Brener, Y strains, Colombiana, protein farnesyltransferase, P. falciparum, Aldose reductase (ALR2), in situ cross-docking (ISCD), AutoDock4 (AD4), CCK-2R, 1H-NMR, X-ray crystallographic analyses, HIV-1 reverse transcriptase, tetrahydroquinolines, protein farnesyltransferase (PFT), FAAH, Kasumi1, EOL-1, CTV1, chronic myeloid leukemia, PG cell line, ENPP2, MBOBT, Gibberalla zeae, Fusarium oxysporum, Cercospora rachidicola, Physalospora piricola, Alternaria solani, Microsporum canis, Trichophyton mentagrophyte, Trichophyton rubrum, Epidermophyton floccosum, Candida albicans, glucagon-like peptide-1, DPPIV-inhibitory activity
Current Bioactive Compounds
Title: Bioactive Compounds Containing Benzoxadiazole, Benzothiadiazole, Benzotriazole
Volume: 6 Issue: 4
Author(s): Antonio Palumbo Piccionello and Annalisa Guarcello
Affiliation:
Keywords: Heterocycles, benzoxadiazole, benzofuroxan, benzothiadiazole, benzotriazole, biologically active compounds, Antitumorals, GSTs, NBDHEX, MRP1, Cisplatin, Electrospray ionization mass spectrometry, fluorescence analysis, TRAF6 ligase assay, Mycobacterium tuberculosis, GOLD, FLEXX, whole-cell assay, Mycobacterium smegmatis, P. aeruginosa, S. aureus, Helicobacter pylori, Trypanosoma cruzi, ESR spectroscopy, Tulahuen 2, CL Brener, Y strains, Colombiana, protein farnesyltransferase, P. falciparum, Aldose reductase (ALR2), in situ cross-docking (ISCD), AutoDock4 (AD4), CCK-2R, 1H-NMR, X-ray crystallographic analyses, HIV-1 reverse transcriptase, tetrahydroquinolines, protein farnesyltransferase (PFT), FAAH, Kasumi1, EOL-1, CTV1, chronic myeloid leukemia, PG cell line, ENPP2, MBOBT, Gibberalla zeae, Fusarium oxysporum, Cercospora rachidicola, Physalospora piricola, Alternaria solani, Microsporum canis, Trichophyton mentagrophyte, Trichophyton rubrum, Epidermophyton floccosum, Candida albicans, glucagon-like peptide-1, DPPIV-inhibitory activity
Abstract: The aim of this review is the coverage of recent literature (2007-2009) on bioactive compounds containing benzoxadiazole, benzothiadiazole and benzotriazole nucleus, as central core as well as substituent in the context of SAR studies. Reviews sections are organized on the basis of heterocycle contained in drug structure and subdivided for represented main activities (Antitumorals, antiviral, antibacterial, antifungal agents, analgesics, etc.).
Export Options
About this article
Cite this article as:
Palumbo Piccionello Antonio and Guarcello Annalisa, Bioactive Compounds Containing Benzoxadiazole, Benzothiadiazole, Benzotriazole, Current Bioactive Compounds 2010; 6 (4) . https://dx.doi.org/10.2174/157340710793237308
DOI https://dx.doi.org/10.2174/157340710793237308 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Signal Transduction Inhibitors in the Treatment of Breast Cancer
Current Medicinal Chemistry - Anti-Cancer Agents NOTCH Signaling as a Novel Cancer Therapeutic Target
Current Cancer Drug Targets Interaction Between Estrogen Receptor Alpha and Insulin/IGF Signaling in Breast Cancer
Current Cancer Drug Targets Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions
Current Vascular Pharmacology New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Cancer Chemoprevention by Dietary Phytochemicals: Promises and Pitfalls
Current Pharmaceutical Biotechnology The Emergence of Non-coding RNAs as Versatile and Efficient Therapeutic Tools
Current Gene Therapy Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease
Current Pharmaceutical Design Temporal Expression of miRNAs in Laser Capture Microdissected Palate Medial Edge Epithelium from Tgfβ3<sup>-/-</sup> Mouse Fetuses
MicroRNA A Systems Biology Road Map for the Discovery of Drugs Targeting Cancer Cell Metabolism
Current Pharmaceutical Design Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Current Pharmaceutical Biotechnology Small-molecule Inhibitors of Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinases (TK)
Current Pharmaceutical Design Endothelial Progenitor Cells: A Vascular Perspective for Inflammatory Rheumatic Disorders
Current Rheumatology Reviews SERMs: Evolutionary Chemistry, Revolutionary Biology
Current Pharmaceutical Design Robotic Assisted Surgery in Gynecology: Current Insights and Future Perspectives
Recent Patents on Biotechnology Glucose Transporters in Sex Steroid Hormone Related Cancer
Current Vascular Pharmacology Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Current Cancer Drug Targets PET Imaging to Monitor Cancer Therapy
Current Pharmaceutical Biotechnology bHLH Transcription Factors Inhibitors for Cancer Therapy: General Features for In Silico Drug Design
Current Medicinal Chemistry Genetic Polymorphisms of Drug Metabolising Enzymes and Drug Transporters in Relation to Cancer Risk
Current Cancer Therapy Reviews